v3.26.1
Interim Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Number of ordinary shares
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2024   $ 275,015 $ (267,331) $ 7,684
Balance (in Shares) at Dec. 31, 2024 10,190,904      
Share-based compensation   2,875 2,875
Issuance of Ordinary shares, abeyance shares and warrants, net [1]   28,162 28,162
Issuance of Ordinary shares, abeyance shares and warrants, net (in Shares) [1] 4,492,875      
Exercise of pre-funded warrants   [2] [2]
Exercise of pre-funded warrants (in Shares) 970,350      
Net loss   (18,245) (18,245)
Balance at Jun. 30, 2025   306,052 (285,576) 20,476
Balance (in Shares) at Jun. 30, 2025 15,654,129      
Balance at Dec. 31, 2025   312,473 (301,500) $ 10,973
Balance (in Shares) at Dec. 31, 2025 18,204,002     18,204,002
Share-based compensation   1,462 $ 1,462
Issuance of Ordinary shares, abeyance shares and warrants, net [3]   8,521 8,521
Issuance of Ordinary shares, abeyance shares and warrants, net (in Shares) [3] 1,814,655      
Exercise of pre-funded warrants   [2] [2]
Exercise of pre-funded warrants (in Shares) 290,859      
Exercise of options   9 9
Exercise of options (in Shares) 2,250      
Net loss   (15,577) (15,577)
Balance at Jun. 30, 2026   $ 322,465 $ (317,077) $ 5,388
Balance (in Shares) at Jun. 30, 2026 20,311,766     20,311,766
[1] Net of issuance cost of $72.
[2] Amount less than $1.
[3] Net of issuance cost of $115.